GlassScriptPhysician profile
Gene Wong
NPI 1386955565
$6,012.14
in general payments reported to CMS, 2019-2025
18 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $376 · 2021: $868 · 2022: $1,064 · 2023: $353 · 2024: $1,027 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,546.04 | 2019-2025 | Precision7, Total30, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $889.14 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $597.56 | 2022-2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $403.19 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $348.42 | 2019-2021 | |
| Biotissue Holdings INC. | $304.41 | 2025 | |
| Coopervision INC. | $293.01 | 2020-2025 | Clariti Contact Lens, Myday Contact Lens |
| Optovue, INC. | $248.73 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $229.19 | 2019-2021 | |
| Optos, INC. | $208.85 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $134.25 | 2024 | Cirrus Hd-Oct |
| Sight Sciences, INC. | $128.94 | 2024 | Omni Surgical System |
| Dompe US, INC. | $124.99 | 2023 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $123.13 | 2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $119.16 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $115.78 | 2021 | |
| Allergan, INC. | $113.17 | 2022 | |
| Rxsight INC | $84.18 | 2024 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.